When acute toxoplasmosis occurs in a patient with immunodeficiency, prompt and appropriate treatment is critical. This clinical scenario carries a substantially higher risk of a fatal outcome without timely intervention.
This protocol addresses active toxoplasmosis in an immunodeficient patient. Immunodeficiency significantly alters the risk profile: toxoplasmosis in this population is often fatal if not treated, making the choice and execution of the treatment regimen essential.
Management requires a specific multi-agent combination regimen with an extended treatment course that continues well beyond clinical resolution. The full protocol — including all agents, their sequencing, and the complete duration criteria — is available via the link below.